Are venetoclax and venetoclax the same medicine? The truth behind the name

Venetoclax and Venetoclax are different names for the same drug. In fact, Venetoclax is the international generic name of the drug, while Venetoclax is its translation or brand name in the Chinese market. Such name differences are not uncommon in international drug nomenclature, especially when drugs have different trademark or generic names in different regions and markets around the world.

Venetoclax was jointly developed by Swiss pharmaceutical companies Roche (Roche) and AbbVie. As a targeted therapy drug, it is mainly used to treat chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) . The background of drug development shows that it mainly inhibits the function of BCL-2 protein to prevent tumor cells from escaping normal programmed death, thereby effectively inhibiting the growth of leukemia.

Drug names may vary in different regions and markets. For example, the generic name and market-approved name of Venetoclax in the United States, Europe and other countries and regions are consistent. In China, the drug is translated as Venecla to better suit local drug naming habits and promotion strategies. Whether it is venetoclax or venetoclax, they all refer to the same drug, a BCL-2 inhibitor used to treat leukemia.

This difference in names is often based on the marketing and regulatory requirements of the drug around the world. Different countries and regions usually have their own drug name standards and language habits, so the names of drugs will be adjusted when they are launched on the market to better comply with local cultural and legal regulations. Behind the name of a drug, it not only reflects the commercialization strategy, but also involves the compliance requirements for drug registration and sales.

Reference materials:https://www.venclexta.com/